Kamień, Poland

Elżbieta Maziarz


Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Kamień, PL (2018 - 2019)
  • Kamien, PL (2020)

Company Filing History:


Years Active: 2018-2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Elżbieta Maziarz: Innovator in Chitinase Inhibitors

Introduction

Elżbieta Maziarz is a prominent inventor based in Kamień, Poland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target human chitinase. With a total of 3 patents, Maziarz is recognized for his innovative approaches to treating various diseases.

Latest Patents

Maziarz's latest patents include the development of substituted amino triazoles that serve as human chitinase inhibitors. These compounds are characterized by a piperidinyl ring that is further substituted with a heterocyclic ring. The primary function of these compounds is to inhibit acidic mammalian chitinase and chitotriosidase. The patents also disclose methods for using these compounds to treat asthma reactions caused by allergens, as well as a range of conditions including acute and chronic inflammatory diseases, autoimmune diseases, dental diseases, neurologic diseases, metabolic diseases, liver diseases, polycystic ovary syndrome, endometriosis, and cancer.

Career Highlights

Elżbieta Maziarz is currently associated with Oncoarendi Therapeutics S.A., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the pharmaceutical industry, particularly in the area of therapeutic innovations.

Collaborations

Maziarz collaborates with notable colleagues such as Marzena Mazur and Robert Koralewski, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Elżbieta Maziarz's contributions to the field of medicinal chemistry, particularly through his patents on chitinase inhibitors, highlight his role as an influential inventor. His ongoing work at Oncoarendi Therapeutics S.A. continues to pave the way for new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…